Sirtuin‐3 (SIRT3), a novel potential therapeutic target for oral cancer

Abstract

The current investigation revealed a novel role for SIRT3 in oral cancer carcinogenesis as a promoter of cell proliferation and survival, thus implicating SIRT3 as a new potential therapeutic target to treat oral cancer.